Prognostic value of risk stratification using blood biochemical parameters in Japanese patients with metastatic renal cell carcinoma treated by nivolumab

被引:0
|
作者
Yamamoto, Yoshiaki
Matsuyama, Hideyasu
Matsumoto, Hiroaki
Sakano, Shigeru
Fujii, Nakanori
Oba, Kazuo
Yamamoto, Mitsutaka
Kamiryo, Yoriaki
Hiragino, Takeshi
Nagao, Kazuhiro
Takai, Kimio
Aoki, Akihiko
Yoshihiro, Satoru
Tsukamoto, Manabu
Akao, Jumpei
Kitahara, Seiji
Misumi, Taku
Komatsu, Hirotaka
Oka, Shintaro
Suga, Akinobu
机构
[1] Yamaguchi Univ, Grad Sch Med, Ube, Yamaguchi, Japan
[2] Yamaguchi Univ, Ube, Yamaguchi, Japan
[3] Kokura Mem Hosp, Dept Urol, Kitakyushu, Japan
[4] Tokuyama Cent Hosp, Dept Urol & Nephrol, Shunan, Japan
[5] Saiseikai Yamaguchi Gen Hosp, Dept Urol, Yamaguchi, Japan
[6] Yamaguchi Grand Med Ctr, Dept Urol, Hofu, Japan
[7] Shimonoseki Saisekai Toyoura Hosp, Dept Urol, Shimonoseki, Yamaguchi, Japan
[8] Nagato Gen Hosp, Dept Urol, Nagato, Japan
[9] Shuto Gen Hosp, Yanai, Japan
[10] Saiseikai Shimonoseki Gen Hosp, Dept Urol, Shimonoseki, Yamaguchi, Japan
[11] Masuda Red Cross Hosp, Dept Urol, Masuda, Japan
[12] Shimonoseki City Hosp, Dept Urol, Shimonoseki, Yamaguchi, Japan
[13] Yamaguchi Red Cross Hosp, Dept Urol, Yamaguchi, Japan
[14] Ogori Daiichi Gen Hosp, Yamaguchi, Japan
[15] Sanyo Onoda Municipal Hosp, Sanyo Onoda, Japan
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
724
引用
收藏
页数:2
相关论文
共 50 条
  • [31] Pseudoprogression: A case of metastatic renal clear cell carcinoma treated with nivolumab
    Tabei, Tadashi
    Tsuura, Yukio
    Kobayashi, Kazuki
    PATHOLOGY INTERNATIONAL, 2018, 68 (11) : 627 - 629
  • [32] Prognostic factors and risk classifications for patients with metastatic renal cell carcinoma
    Shinohara, Nobuo
    Abe, Takashige
    INTERNATIONAL JOURNAL OF UROLOGY, 2015, 22 (10) : 888 - 897
  • [33] Prognostic and predictive factors to nivolumab in patients with metastatic renal cell carcinoma: a single center study
    Mollica, Veronica
    Rizzo, Alessandro
    Tassinari, Elisa
    Giunchi, Francesca
    Schiavina, Riccardo
    Fiorentino, Michelangelo
    Brunocilla, Eugenio
    Ardizzoni, Andrea
    Massari, Francesco
    ANTI-CANCER DRUGS, 2021, 32 (01) : 74 - 81
  • [34] Association of lung immune prognostic index with survival outcomes in patients with metastatic renal cell carcinoma treated with nivolumab plus ipilimumab
    Yamashita, Shimpei
    Hamamoto, Shuzo
    Furukawa, Junya
    Fujita, Kazutoshi
    Takahashi, Masayuki
    Miyake, Makito
    Ito, Noriyuki
    Iwamoto, Hideto
    Kohjimoto, Yasuo
    Hara, Isao
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2024, 54 (06) : 722 - 729
  • [35] Prognostic value of fat loss in patients with metastatic clear cell renal cell carcinoma treated with immune checkpoint inhibition
    Lee, J.
    Lee, S. M.
    Lee, J. H.
    Hwang, S.
    Jee, B.
    Kim, J.
    Chung, J. H.
    Song, W.
    Sung, H. H.
    Jeon, H. G.
    Jeong, B. C.
    Seo, S., I
    Jeon, S. S.
    Lee, H. M.
    Park, S. H.
    Kwon, G. Y.
    Kang, M.
    EUROPEAN UROLOGY, 2023, 83 : S488 - S489
  • [36] Prognostic factors for survival in previously treated patients with metastatic renal cell carcinoma
    Motzer, RJ
    Bacik, J
    Schwartz, LH
    Reuter, V
    Russo, P
    Marion, S
    Mazumdar, M
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (03) : 454 - 463
  • [37] PROGNOSTIC FACTORS FOR SURVIVAL IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA TREATED WITH CHEMOTHERAPY
    Davidov, Deyan
    JOURNAL OF IMAB, 2016, 22 (01): : 1045 - 1049
  • [38] Prognostic value of VHL gene alteration in patients with metastatic renal cell carcinoma
    Nosovt, D. A.
    Yakovleva, E. S.
    Fedyanin, M. Yu.
    Chekini, D. A.
    Sinitsyna, M. N.
    Savelov, N. A.
    Mikhailenkoc, D. S.
    Zaletayevc, D. V.
    Lyubchenkol, L. N.
    Tjulandini, S. A.
    ONKOUROLOGIYA, 2011, 7 (03): : 47 - 56
  • [39] Prognostic value of sarcopenia in metastatic renal cell carcinoma patients: A systematic review
    Tancherla, A.
    Wijovi, F.
    Halim, D. A.
    Kurniawan, A.
    ANNALS OF ONCOLOGY, 2020, 31 : S1322 - S1322
  • [40] Prognostic Value of Systemic Inflammatory Biomarkers in Patients with Metastatic Renal Cell Carcinoma
    Marta, Guilherme Nader
    Velho, Pedro Isaacsson
    Bonadio, Renata R. C.
    Nardo, Mirella
    Faraj, Sheila F.
    de Azevedo Souza, Manoel Carlos L.
    Muniz, David Q. B.
    Bastos, Diogo Assed
    Dzik, Carlos
    PATHOLOGY & ONCOLOGY RESEARCH, 2020, 26 (04) : 2489 - 2497